Quarterly Result31 Oct 2026, 07:41 pm
Shree Ganesh Remedies Declares Q2 FY27 Financial Results
AI Summary
Shree Ganesh Remedies Ltd announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved the standalone and consolidated results, along with the Limited Review Reports from Chaudhary Shah & Associates LLP. The results were prepared in accordance with Indian Accounting Standards (Ind AS) 34. The company's subsidiary, SGRL USA INC, reported minimal financial activity for the period.
Key Highlights
- Board approved unaudited financial results for Q2 FY27.
- Standalone and consolidated results were declared.
- Auditors provided Limited Review Reports.
- Results comply with Ind AS 34 and SEBI LODR regulations.
- Subsidiary SGRL USA INC had negligible financial impact.
Price Impact
More from SGRL